CONMED Cites Better Market and Execution in Overperformance
The company grew 22% in 1Q23 due to improving surgical volumes and working through its warehouse-driven backlog from late-2022. Apr 28, 2023
We've found 290 results
Strategic Alliances to Gain Greater Traction in Orthopedics
The French spine company Implanet has executed multiple device company partnerships to expand its portfolio. We asked the CEO about lessons he's learned and advice he would give to other orthopedic executives. Mar 23, 2023
Enovis CEO Talks Tech, ASCs and Strategic Focus
We spoke to Enovis CEO Matt Trerotola about foundational implant technologies, ASC penetration, tech adoption and successful M&A deals. Mar 21, 2023
Anika’s New Launches Set Stage for 2023 and Beyond
The company's orthopedic sales grew in the high single digits for 2022, and it launched new cornerstone products in high-growth segments. Mar 14, 2023
OrthoPediatrics Continued Growth Trend in 2022
With the exception of the pandemic-ridden 2020, OrthoPediatrics has grown in excess of 20% every year since its founding. Mar 13, 2023
Hospital/Device Company Partnership Trends to Consider
As orthopedic executives think about 2023 and beyond, we provide perspective and advice about extensive issues that current and potential hospital customers face. Mar 07, 2023
How Orthopedic Companies Can Leverage the Changing Role of Hospital Purchasing
Hospital purchasing trends create opportunities for orthopedic companies to further invest in their relationships with customers. Feb 28, 2023
Orthopedic Execs Talk Tech, M&A and Surgical Volumes
Ortho execs on enabling technology’s important role in implant sales, recent M&A deals that worked and improving surgical procedure volumes. Feb 27, 2023
3 Market Trends in Joint Replacement
New technologies, increasing cementless adoption and volume-based procurement in China set the stage for a dynamic year in joint replacement. Feb 24, 2023
DePuy Synthes Procedure Recovery Offset by China Disruption
The company closed 2022 with a strong sales performance in the U.S. but endured COVID surges in China and double-digit currency headwinds. Jan 26, 2023
